Federated Hermes
FBRX icon

Federated Hermes’s Forte Biosciences FBRX Stock Holding History

Federated Hermes’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.8M Buy
2,110,516
+345,000
+20% +$8.18M 0.06% 291
2026
Q1 		$45.7M Hold
1,765,516
– – 0.07% 281
2025
Q4 		$48.1M Buy
1,765,516
+130,136
+8% +$2.28M 0.08% 269
2025
Q3 		$24.5M Buy
1,635,380
+563,147
+53% +$6.49M 0.04% 396
2025
Q2 		$13.9M Buy
+1,072,233
New +$9.23M 0.03% 505
2023
Q1 		– Sell
-72
Closed -$1.79K – 2166
2022
Q4 		$1.79K Sell
72
-59
-45% -$1.51K ﹤0.01% 2016
2022
Q3 		$3K Sell
131
-1
-0.8% -$32 ﹤0.01% 1933
2022
Q2 		$4K Buy
132
+15
+13% +$477 ﹤0.01% 1908
2022
Q1 		$4K Buy
117
+51
+77% +$1.93K ﹤0.01% 1974
2021
Q4 		$4K Buy
+66
New +$4.44K ﹤0.01% 2010
2020
Q3 		– Sell
-1
Closed -$1K – 2273
2020
Q2 		$1K Sell
1
-1
-50% -$447 ﹤0.01% 2142
2020
Q1 		$1K Buy
+2
New +$782 ﹤0.01% 2101
2019
Q4 		– Hold
0
– – – 2089
2019
Q3 		– Hold
0
– – – 2098
2019
Q1 		– Sell
-1,283
Closed -$3.95M – 2172
2018
Q4 		$3.95M Buy
1,283
+666
+108% +$2.87M 0.01% 805
2018
Q3 		$3.6M Buy
+617
New +$2.35M 0.01% 903
2018
Q2 		– Hold
0
– – – 2139

Other funds holding FBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Federated Hermes's FBRX Position: Q2 2026 in Review

Federated Hermes increased its Forte Biosciences (FBRX) stake by 20% in Q2 2026, buying an estimated $8.18M and bringing the position to 2,110,516 shares worth $44.8M. The position accounts for 0.06% of the portfolio, ranked #291.

Federated Hermes first reported a position in FBRX in Q3 2018 and has held it in 14 quarters since. The position peaked at $48.1M in Q4 2025. 56 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Federated Hermes held 2,110,516 shares of Forte Biosciences worth $44.8M as of Q2 2026.
  • Federated Hermes bought 345,000 Forte Biosciences shares in Q2 2026, an estimated $8.18M.
  • Forte Biosciences made up 0.06% of Federated Hermes's portfolio in Q2 2026, its #291 holding.
  • Federated Hermes first reported a position in Forte Biosciences in Q3 2018 and has held it in 14 quarters since.
  • Federated Hermes's Forte Biosciences position peaked at $48.1M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.